Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Journal of Affective Disorders
|
September 8, 2009
The impact of comorbid posttraumatic stress disorder on bipolar disorder patients
Lucas C Quarantini, Angela Miranda-Scippa, Fabiana Nery-Fernandes, et al.
Harvard Review of Psychiatry
|
March 10, 2022
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Igor D Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi, et al.
Comprehensive Psychiatry
|
November 20, 2010
Comorbid major depression in obsessive-compulsive disorder patients
Lucas C Quarantini, Albina Rodrigues Torres, Aline S Sampaio, et al.
Clinical Neuropharmacology
|
September 12, 2022
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial
Graziele Beanes, Ana Teresa Caliman-Fontes, Breno Souza-Marques, et al.
Plos One
|
October 24, 2014
Hepatitis C virus infection as a traumatic experience
Mychelle Morais-de-Jesus, Renato Daltro-Oliveira, Karine Miranda Pettersen, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression
Breno Souza-Marques, Manuela Telles, Gustavo C Leal, et al.
Psychiatry Research
|
March 15, 2023
Psychopathological symptoms in parents and siblings of people on the autism spectrum: A systematic review and meta-analysis
Ana Cecília Bispo-Torres, Rita Lucena, Ivo César Tavares-Rodrigues, et al.
Journal of Psychiatric Research
|
June 29, 2023
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D Bandeira, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Human Psychopharmacology
|
February 18, 2022
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
Ana Paula Jesus-Nunes, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Journal of Psychiatric Research
|
May 15, 2021
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
Rodrigo P Mello, Mariana V F Echegaray, Ana Paula Jesus-Nunes, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Journal of Affective Disorders
|
September 8, 2009
The impact of comorbid posttraumatic stress disorder on bipolar disorder patients
Lucas C Quarantini, Angela Miranda-Scippa, Fabiana Nery-Fernandes, et al.
Harvard Review of Psychiatry
|
March 10, 2022
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Igor D Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi, et al.
Comprehensive Psychiatry
|
November 20, 2010
Comorbid major depression in obsessive-compulsive disorder patients
Lucas C Quarantini, Albina Rodrigues Torres, Aline S Sampaio, et al.
Clinical Neuropharmacology
|
September 12, 2022
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial
Graziele Beanes, Ana Teresa Caliman-Fontes, Breno Souza-Marques, et al.
Plos One
|
October 24, 2014
Hepatitis C virus infection as a traumatic experience
Mychelle Morais-de-Jesus, Renato Daltro-Oliveira, Karine Miranda Pettersen, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression
Breno Souza-Marques, Manuela Telles, Gustavo C Leal, et al.
Psychiatry Research
|
March 15, 2023
Psychopathological symptoms in parents and siblings of people on the autism spectrum: A systematic review and meta-analysis
Ana Cecília Bispo-Torres, Rita Lucena, Ivo César Tavares-Rodrigues, et al.
Journal of Psychiatric Research
|
June 29, 2023
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D Bandeira, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Human Psychopharmacology
|
February 18, 2022
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
Ana Paula Jesus-Nunes, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Journal of Psychiatric Research
|
May 15, 2021
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
Rodrigo P Mello, Mariana V F Echegaray, Ana Paula Jesus-Nunes, et al.
Page
of 9